BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18059396)

  • 1. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.
    Allgood PC; Warwick J; Warren RM; Day NE; Duffy SW
    Br J Cancer; 2008 Jan; 98(1):206-9. PubMed ID: 18059396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.
    Fielder HM; Warwick J; Brook D; Gower-Thomas K; Cuzick J; Monypenny I; Duffy SW
    J Med Screen; 2004; 11(4):194-8. PubMed ID: 15563774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia.
    McCann J; Duffy S; Day N;
    Br J Cancer; 2001 Feb; 84(3):423-8. PubMed ID: 11161411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.
    Day N; McCann J; Camilleri-Ferrante C; Britton P; Hurst G; Cush S; Duffy S
    J Med Screen; 1995; 2(4):180-5. PubMed ID: 8719145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.
    Gabe R; Tryggvadóttir L; Sigfússon BF; Olafsdóttir GH; Sigurdsson K; Duffy SW
    Acta Radiol; 2007 Nov; 48(9):948-55. PubMed ID: 18080359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial.
    van der Waal D; Broeders MJ; Verbeek AL; Duffy SW; Moss SM
    Epidemiology; 2015 Jul; 26(4):590-6. PubMed ID: 25767987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
    Berrington de González A; Reeves G
    Br J Cancer; 2005 Sep; 93(5):590-6. PubMed ID: 16136033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ongoing case-control study to evaluate the NHS breast screening programme.
    Massat NJ; Sasieni PD; Parmar D; Duffy SW
    BMC Cancer; 2013 Dec; 13():596. PubMed ID: 24330588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.
    Puliti D; Miccinesi G; Collina N; De Lisi V; Federico M; Ferretti S; Finarelli AC; Foca F; Mangone L; Naldoni C; Petrella M; Ponti A; Segnan N; Sigona A; Zarcone M; Zorzi M; Zappa M; Paci E;
    Br J Cancer; 2008 Aug; 99(3):423-7. PubMed ID: 18665188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
    Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
    Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.
    van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M
    J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits and harms of breast cancer screening: an independent review.
    Independent UK Panel on Breast Cancer Screening
    Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study to evaluate the impact of the breast screening programme on mortality in England.
    Maroni R; Massat NJ; Parmar D; Dibden A; Cuzick J; Sasieni PD; Duffy SW
    Br J Cancer; 2021 Feb; 124(4):736-743. PubMed ID: 33223536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.